Oramed Pharmaceuticals (ORMP) Capital Expenditures (2011 - 2026)
Oramed Pharmaceuticals (ORMP) reported Capital Expenditures of $5000.0 for Q1 2026, up 66.67% on a YoY basis from $3000.0 in Q1 2025, and up 150.0% quarter-over-quarter from $2000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Capital Expenditures (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Capital Expenditures for 15 years, with the latest figure at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 66.67% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $11000.0 (down 42.11% YoY), and the FY2025 full-year result was $9000.0, down 50.0% from the prior year.
- Capital Expenditures for Q1 2026 stood at $5000.0, up from $2000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $308000.0 in Q4 2022, with the low at $2000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $52133.3 across 5 years, with a median of $11000.0 in 2024.
- The largest YoY upside for Capital Expenditures was 323.4% in 2023 against a maximum downside of 99.03% in 2023.
- Oramed Pharmaceuticals' Capital Expenditures stood at $308000.0 in 2022, then slumped by 99.03% to $3000.0 in 2023, then surged by 266.67% to $11000.0 in 2024, then slumped by 81.82% to $2000.0 in 2025, then soared by 150.0% to $5000.0 in 2026.
- The last three Capital Expenditures figures came in at $5000.0 (Q1 2026), $2000.0 (Q4 2025), and $4000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |